194 related articles for article (PubMed ID: 3495006)
21. Interstitial deletion of the long arm of chromosome 5 (5q-) in leukemia and other hematological disorders: clinical and biological relevance of variable breakpoint patterns.
Gyger M; Perreault C; Pichette R; Forest L; Lussier P
Leuk Res; 1986; 10(1):9-15. PubMed ID: 3945105
[TBL] [Abstract][Full Text] [Related]
22. Molecular cloning and characterization of a cDNA for human granulocyte colony-stimulating factor (G-CSF) from a glioblastoma multiforme cell line and localization of the G-CSF gene to chromosome band 17q21.
Tweardy DJ; Cannizzaro LA; Palumbo AP; Shane S; Huebner K; Vantuinen P; Ledbetter DH; Finan JB; Nowell PC; Rovera G
Oncogene Res; 1987 Aug; 1(3):209-20. PubMed ID: 2453015
[TBL] [Abstract][Full Text] [Related]
23. 5q-: pathogenetic importance of the common deleted region and clinical consequences of the entire deleted segment.
Pedersen B
Anticancer Res; 1993; 13(5C):1913-6. PubMed ID: 8267400
[TBL] [Abstract][Full Text] [Related]
24. De novo acute leukemia with a sole 5q-: morphological, immunological, and clinical correlations.
Duchayne E; Dastugue N; Kuhlein E; Huguet F; Pris J
Leuk Lymphoma; 1993 Nov; 11(5-6):387-92. PubMed ID: 8124211
[TBL] [Abstract][Full Text] [Related]
25. Consistent loss of the D5S89 locus mapping telomeric to the interleukin gene cluster and centromeric to EGR-1 in patients with 5q- chromosome.
Nagarajan L; Zavadil J; Claxton D; Lu X; Fairman J; Warrington JA; Wasmuth JJ; Chinault AC; Sever CE; Slovak ML
Blood; 1994 Jan; 83(1):199-208. PubMed ID: 8274735
[TBL] [Abstract][Full Text] [Related]
26. Expression of FLT3 receptor and response to FLT3 ligand by leukemic cells.
Drexler HG
Leukemia; 1996 Apr; 10(4):588-99. PubMed ID: 8618433
[TBL] [Abstract][Full Text] [Related]
27. c-src is consistently conserved in the chromosomal deletion (20q) observed in myeloid disorders.
Le Beau MM; Westbrook CA; Diaz MO; Rowley JD
Proc Natl Acad Sci U S A; 1985 Oct; 82(19):6692-6. PubMed ID: 2413444
[TBL] [Abstract][Full Text] [Related]
28. Interleukin-5 is at 5q31 and is deleted in the 5q- syndrome.
Sutherland GR; Baker E; Callen DF; Campbell HD; Young IG; Sanderson CJ; Garson OM; Lopez AF; Vadas MA
Blood; 1988 Apr; 71(4):1150-2. PubMed ID: 3258537
[TBL] [Abstract][Full Text] [Related]
29. Molecular organization of the cytokine gene cluster, involving the human IL-3, IL-4, IL-5, and GM-CSF genes, on human chromosome 5.
van Leeuwen BH; Martinson ME; Webb GC; Young IG
Blood; 1989 Apr; 73(5):1142-8. PubMed ID: 2564789
[TBL] [Abstract][Full Text] [Related]
30. The 5q-anomaly.
Van den Berghe H; Vermaelen K; Mecucci C; Barbieri D; Tricot G
Cancer Genet Cytogenet; 1985 Jul; 17(3):189-255. PubMed ID: 3891074
[TBL] [Abstract][Full Text] [Related]
31. Cytogenetic features of 5q deletion and 5q- syndrome in myelodysplastic syndrome in Korea; marker chromosomes proved to be chromosome 5 with interstitial deletion by fluorescence in situ hybridization.
Lee HR; Oh B; Hong DS; Zang DY; Yoon HJ; Kim HJ; Kim I; Ahn JS; Cheong JW; Lee KA; Cho KS; Lee MH; Bang SM; Kim TY; Yun YM; Min YH; Lee YK; Lee DS;
Cancer Genet Cytogenet; 2010 Dec; 203(2):193-202. PubMed ID: 21156233
[TBL] [Abstract][Full Text] [Related]
32. 5q- chromosome. Evidence for complex interstitial breaks in a case of refractory anemia with excess blasts.
Nagarajan L; Zhao L; Lu X; Warrington JA; Wasmuth JJ; Siciliano M; Deisseroth AB; Liang JC
Cancer Genet Cytogenet; 1994 May; 74(1):8-12. PubMed ID: 8194054
[TBL] [Abstract][Full Text] [Related]
33. Delineation by molecular cytogenetics of 5q deletion breakpoints in myelodyplastic syndromes and acute myeloid leukemia.
Royer-Pokora B; Trost D; Müller N; Hildebrandt B; Germing U; Beier M
Cancer Genet Cytogenet; 2006 May; 167(1):66-9. PubMed ID: 16682289
[TBL] [Abstract][Full Text] [Related]
34. Fourth International Workshop on Chromosomes in Leukemia 1982: Deletion of 5q.
Van den Berghe H; Le Beau M; Bernheim A
Cancer Genet Cytogenet; 1984 Mar; 11(3):296-9. PubMed ID: 6704932
[TBL] [Abstract][Full Text] [Related]
35. Chromosome 7 long arm deletion in myeloid disorders: a narrow breakpoint region in 7q22 defined by molecular mapping.
Kere J; Ruutu T; Davies KA; Roninson IB; Watkins PC; Winqvist R; de la Chapelle A
Blood; 1989 Jan; 73(1):230-4. PubMed ID: 2562922
[TBL] [Abstract][Full Text] [Related]
36. Clinical and prognostic implications of chromosome 5q deletions: 96 high resolution studied patients.
Pedersen B; Jensen IM
Leukemia; 1991 Jul; 5(7):566-73. PubMed ID: 2072742
[TBL] [Abstract][Full Text] [Related]
37. 5q- and t(2;11) in a patient with M2 acute non-lymphocytic leukemia. Case report.
Testoni N; Zaccaria A; Celso B; Tassinari A; Rosti G; Tura S
Haematologica; 1989; 74(6):595-9. PubMed ID: 2628243
[TBL] [Abstract][Full Text] [Related]
38. The thrombin receptor gene is centromeric to the common proximal breakpoint in patients with the 5q- syndrome: identification of a previously unrecognized chromosome 5 inversion.
Demetrick DJ; Dewald GW; Lanman J; Bahou WF
Br J Haematol; 1996 Feb; 92(2):339-43. PubMed ID: 8602997
[TBL] [Abstract][Full Text] [Related]
39. Chromosome 5q deletion and epigenetic suppression of the gene encoding alpha-catenin (CTNNA1) in myeloid cell transformation.
Liu TX; Becker MW; Jelinek J; Wu WS; Deng M; Mikhalkevich N; Hsu K; Bloomfield CD; Stone RM; DeAngelo DJ; Galinsky IA; Issa JP; Clarke MF; Look AT
Nat Med; 2007 Jan; 13(1):78-83. PubMed ID: 17159988
[TBL] [Abstract][Full Text] [Related]
40. Chromosomal mapping of the mouse IL-4 and human IL-5 genes.
Takahashi M; Yoshida MC; Satoh H; Hilgers J; Yaoita Y; Honjo T
Genomics; 1989 Jan; 4(1):47-52. PubMed ID: 2563351
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
